Sacubitril/valsartan in chronic symptomatic heart failure: a real world experience of delivery and outcomes.

被引：0
|
作者：
Kearney, A. Aileen [1 ]
Hill, L. [1 ]
Davidson, J. [1 ]
Mc Clure, C. [1 ]
Dixon, L. [1 ]
机构：
[1] Royal Victoria Hosp, Belfast, Antrim, North Ireland
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1662
引用
收藏
页码：411 / 411
页数：1
相关论文
共 50 条
  • [1] Real world experience with sacubitril/valsartan in heart failure
    Lim, E. L. S.
    Abdullah, E. L.
    Loh, L. C. W.
    Chong, P. F.
    Sia, H. P.
    Sothivadivel, S.
    Lee, J. L.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 417
  • [2] SACUBITRIL/VALSARTAN: REAL WORLD EXPERIENCE OF DELIVERY AND TOLERABILITY
    Crawley, Richard
    Guha, Kaushik
    Kalra, Paul
    Morton, Geraint
    HEART, 2017, 103 : A1 - A2
  • [3] Real world experience of sacubitril and valsartan in patients with heart failure with reduced ejection fraction
    Ganesananthan, S.
    Shah, N.
    Shah, P.
    Phillips, J.
    Elsayed, H.
    Yousef, Z.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 222 - 222
  • [4] Sacubitril/Valsartan in real world heart failure proctice in Asia
    Chu, P. H.
    Hsia, F. C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 412 - 412
  • [5] Predictors of clinical improvement with sacubitril/valsartan in a real world population with chronic heart failure
    Correale, Michele
    Tricarico, Lucia
    Ferraretti, Armando
    Formica, Ennio S.
    Padovano, Giuseppina
    Monaco, Ilenia
    Merolla, Giuseppina
    Tozzi, Valeria
    Di Biase, Matteo
    Iacoviello, Massimo
    Brunetti, Natale Daniele
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2021, 22 (06) : 508 - 510
  • [6] Use of sacubitril-valsartan in heart failure with reduced ejection fraction: real world experience
    Ferreira, F. A. C.
    Cristina, S.
    Raposo, A. F.
    Albuquerque, E. M.
    Nabais, I.
    Matias, C. S.
    Nogueira, M. A.
    Vasconcellos, R. C. A.
    Proenca, G. M. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 228 - 229
  • [7] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, L.
    Gaudio, C.
    Cicogna, F.
    Tota, C.
    Petronilli, V
    Mennuni, S.
    De Ruvo, E.
    Calo, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (18) : 5690 - 5700
  • [8] THE USE OF SACUBITRIL/VALSARTAN: A REAL WORLD EXPERIENCE IN A HIGH VOLUME SPECIALIST HEART FAILURE SERVICE
    Murray, G.
    Barrett, M.
    Earls, S.
    Hammond, M.
    Campbell, P.
    O'Hanlon, R.
    McDonald, K.
    HEART, 2017, 103 : A8 - A9
  • [9] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, Luca
    Ferrari, Ilaria
    Gaudio, Carlo
    Cicogna, Francesco
    Tota, Claudia
    Petronilli, Valentina
    Mennuni, Silvia
    De Ruvo, Ermenegildo
    Calo, Leonardo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [10] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, L.
    Cicogna, F.
    Tota, C.
    Petronilli, V.
    Mennuni, S.
    De Ruvo, E.
    Calo, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 42 - 43
12345